Workshops header

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

  WORKSHOP VENUE FOR ATTENDEES  

New Technologies and Applications for Genome Engineering

DATE: 25th - 28th March 2012
LOCATION: Wiston House, Steyning, West Sussex, UK
ORGANISER:

Elizabeth Fisher
UCL, London, UK

Andrew Smith
University of Edinburgh, Scotland, UK

Victor Tybulewicz
NIMR, London, UK

 
FREE* graduate student/postdoc/PI places available for this Workshop. The next deadline for applications is the 13th February. To apply please complete the
application form. For more information please contact workshops@biologists.com.

Technologies for manipulating the genomes of many cell types are being developed at an increasingly rapid rate using a variety of DNA engineering tools. Current capabilities range from making predesigned nucleotide changes in a gene (single nucleotide changes, insertions, deletions), to generating large scale chromosomal rearrangements including syntenic replacements with foreign chromosomal DNA, and recently to creating an entirely artificial functioning genome. The potential for genome engineering is huge with many applications, for example: to create microorganisms with novel synthetic capabilities; to create via embryonic stem cell manipulation animal models to understand gene function and human disease; and by modification of human somatic cells to correct genetic defects in strategies for therapeutic intervention.

Technologies for genome engineering derive in many cases from adapting naturally occurring in-vivo recombination systems such as homologous recombination, site-specific recombination and transposition to the cell types of interest, and in addition creating entirely novel systems such as zinc finger nucleases by protein engineering. Collectively these provide a sophisticated genetic engineering tool kit that makes possible in principle the design of any desired sequence specific genome manipulation. This workshop will bring together the experts who have pioneered these and emerging technologies in genome engineering together with leaders in their implementation in diverse fields encompassing studies in fundamental biology to biotechnological and biomedical applications. It is anticipated that this will stimulate further thinking into new approaches or refinements to these technologies and exciting ideas for their future application.

* see application form for details.


 

 

 

ATTENDEES
Allan Bradley

Allan Bradley
Sanger Institute, Cambridge, UK

Michele Calos

Michele Calos
Stanford University, Stanford, USA

Mario Capecchi

Mario Capecchi
University of Utah, Salt Lake City, USA

Toni Cathomen

Toni Cathomen
Hannover Medical School, Hannover, Germany

Philippe Duchateau

Philippe Duchateau
Cellectis, Paris, France

Toni Cathomen

Aris Economides
Regeneron Pharmaceuticals,
New York, USA

Elizabeth Fisher

Elizabeth Fisher
UCL, London, UK

Philip Gregory

Philip Gregory
Sangamo BioSciences,
Richmond, USA

Elizabeth Fisher

Yann Herault
ICS, Strasbourg, France

Clyde Hutchison

Clyde Hutchison
Venter Institute, San Diego, USA

Clyde Hutchison

Maria Jasin
Sloan-Kettering Institute, New York, USA

Nancy Jenkins

Nancy Jenkins
The Methodist Hospital Research Institute, Houston, USA

Ivo Lieberam

Ivo Lieberam
King’s College London, London, UK

Pentao Liu

Pentao Liu
Sanger Institute, Cambridge, UK

Andras Nagy

Andras Nagy
Samuel Lunenfeld Research Institute, Toronto, Canada

Andras Nagy

Bill Skarnes
Sanger Institute, Cambridge, UK

Andrew Smith

Andrew Smith
University of Edinburgh, Scotland, UK

Francis Stewart

Francis Stewart
Technical University Dresden, Dresden, Germany

Junji Takeda

Junji Takeda
Osaka University, Osaka, Japan

Victor Tybulewicz

Victor Tybulewicz
NIMR, London, UK

Tian Xu

Tian Xu
Yale University, New Haven, USA

Wolfgang Wurst

Wolfgang Wurst
Helmholtz Zentrum München, Munich-Neuherberg, Germany